Polocaine(r) -mpf (mepivacaine Hci) Injection, Solution
Product Images NDC 51662-1403

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Polocaine(r) -mpf (mepivacaine Hci) (NDC 51662-1403). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Chemical structure of mepivacaine hydrochloride (MEPIVACAINE HCI), showing a piperidine ring with a methyl group, an amide linkage, and a dimethyl-substituted aromatic ring with hydrochloride.*

FDA Label Image

Description (Description 1)

A table presenting the composition of POLOCAINE(R) -MPF injection solutions at different concentrations (1%, 1.5%, 2%) and vial sizes (20 mL, 30 mL, 50 mL). It lists amounts of Mepivacaine hydrochloride, sodium chloride, potassium chloride, calcium chloride, and methylparaben in milligrams per milliliter for each formulation. The table notes all components are in Water for Injection.*

FDA Label Image

Indications & Usage (Indications And Usage)

A table listing dosing concentration percentages used for different regional anesthesia techniques including local infiltration, peripheral nerve blocks, epidural block, and caudal block. The concentrations range from 0.5% to 2% depending on the technique.*

FDA Label Image

Precautions (Precautions)

A table presenting drug classes and corresponding examples. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs. Examples under Local anesthetics notably include mepivacaine, relevant to POLOCAINE(R) -MPF.*

FDA Label Image

Dosage And Administration (Dosage And Administration)

A dosing table for POLOCAINE(R) -MPF (MEPIVACAINE HCI) injection solution displaying recommended concentrations, total dose volumes in mL and mg for various procedures including cervical, brachial, intercostal, pudendal nerve blocks, transvaginal and paracervical blocks, caudal and epidural blocks, infiltration, and therapeutic pain management blocks. It also includes comments on dose administration and special instructions.*

FDA Label Image

Vial Label (Vial Label)

Label for Polocaine-MPF (mepivacaine HCl injection, USP) 1% (10 mg/mL) solution. The label indicates a 30 mL single-dose vial for nerve block, caudal, epidural, and infiltration anesthesia, methylparaben free. Storage instructions specify 20° to 25°C. The label includes the manufacturer Fresenius Kabi USA, LLC and displays a barcode.*

FDA Label Image

Serialized Labeling (Serialized Labeling)

The image shows a vial of POLOCAINE(R)-MPF (mepivacaine HCl) injection, 1% strength (10 mg/mL), labeled for human prescription use. The vial contains 30 mL of solution and is labeled for nerve block, caudal, epidural, and infiltration anesthesia. The product is methylparaben-free and distributed by HF Acquisition Co LLC, Mukilteo, WA.*

FDA Label Image

Case Labeling (51662 1403 3 Case)

Packaging label for POLOCAINE-MPF (Mepivacaine HCl Injection) 1% solution, 30 mL vial, 300 mg per 30 mL (10 mg/mL). The label indicates a case contains 25 vials. It includes NDC 51662-1403-3, lot number, and expiration date. The product is for nerve block, caudal, epidural, and infiltration anesthesia, and is manufactured by HF Acquisition Co LLC.*

FDA Label Image

Rfid Label (51662 1403 3 Rfid)

Partial image of a white label displaying black printed text with numeric codes and a Data Matrix 2D barcode. The text includes references to product identifiers and distributor information. It is from a product distributed by HF Acquisitions Co., LLC, Mukilteo, WA. The label is affixed to a white or light-colored surface, likely associated with pharmaceutical packaging.*

FDA Label Image

Pouch Labeling (51662 1403 2 Pouch)

Label for POLOCAINE-MPF (Mepivacaine HCl Injection) 1%, 300 mg per 30 mL (10 mg/mL), in a 30 mL vial. The label includes NDC 51662-1403-2, lot number 123456, and expiration date 2030-01-01. It states use for nerve block, caudal, epidural, and infiltration anesthesia, with no preservatives and methylparaben-free formulation. Manufactured by HF Acquisition Co LLC, Mukilteo, WA.*

FDA Label Image

Vial Label (51662 1403 2 Vial)

Label for Polocaine-MPF (mepivacaine HCl injection, USP) 1% solution, 10 mg/mL strength, in a 30 mL single dose vial. The label states the product is for nerve block, caudal, epidural, and infiltration anesthesia, not for spinal anesthesia or dental use. It is methylparaben-free and stored at 20° to 25°C. Manufactured by Fresenius Kabi.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.